BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees

Journal of Investigative Dermatology

Volumn 127, Issue 6, 2007, Pages 1387-1391

  Ponti, Giovanni ^a,e   Venesio, Tiziana ^b   Losi, Lorena ^a   Pellacani, Giovanni ^a   Bertario, Lucio ^c   Sala, Paola ^c   Pedroni, Monica ^a   Petti, Consalvo ^b   Maffei, Stefania ^a   Varesco, Liliana ^d   Lerch, Erika ^e   Baggio, Andrea ^a   Bassoli, Sara ^a   Longo, Caterina ^a   Seidenari, Stefania ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; B RAF KINASE; DNA GLYCOSYLASE MUTY; FORMALDEHYDE; K RAS PROTEIN; PARAFFIN;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; COLORECTAL ADENOMA; CONTROLLED STUDY; DNA GLYCOSYLASE MUTY ASSOCIATED POLYPOSIS; DNA ISOLATION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; MISMATCH REPAIR; MULTIPLE CANCER; NUCLEOTIDE SEQUENCE; ONCOGENE N RAS; PATHOGENESIS; PEDIGREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEBACEOUS GLAND DISEASE; SEBACEOUS GLAND HYPERPLASIA; SINGLE STRAND CONFORMATION POLYMORPHISM; SUBSTITUTION REACTION;

ADENOMATOUS POLYPOSIS COLI; ADULT; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS B-RAF; RISK FACTORS; SEBACEOUS GLAND DISEASES;

EID: 34248523574     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700723     Document Type: Article

References (29)

1. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW et al. (1998) A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-57
2. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B et al. (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:484-6
3. Daniotti M, Oggionni M, Ranzani T, Vallacchi V, Campi V, Di Stasi D et al. (2004) BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 23:5968-77
4. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-54
5. de Berker DA, Taylor AE, Quinn Ag, Simpson NB (1996) Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic process? J Am Acad Dermatol 35:696-9
6. Demunter A, Stas M, Degreef H, De Wolf-Peeters C, van den Oord JJ (2001) Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J Invest Dermatol 117:1483-9
7. Enholm S, Hienonen T, Suomalainen A, Lipton L, Tomlinson I, Karja V et al. (2003) Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 163:827-32
8. Feng Y-Z, Shiozawa T, Miyamoto T, Kashima H, Kurai M, Suzuki A et al. (2005) BRAF mutation in endometrial carcinoma and hyperplasia. Correlation with Kras and p53 mutations and mismatch repair protein expression. Clin Cancer Res 11:6133-8
9. Finan MC, Connolly SM (1984) Sebaceous gland tumors and systemic disease. A clinicopathologic analysis. Medicine 63:232-41
10. Foley J, Longely BJ, Wysolmerski JJ, Dreyer BE, Broadus AE, Philbrick WH (1998) PTHrP regulates epidermal differentiation in adult mice. J Invest Dermatol 111:1122-8
11. Gorden A, Osman I, Gai W, He D, Huang W, Davidson A, Dreyer BE, Broadus Ae, Philbrick WH (2003) Analysis of BRAF and NRAS mutations in metastatic melanoma tissues. Cancer Res 63:3955-7
12. He W, Wang D, Ten Dijke P, Wang XJ (2001) Overexpression of Smad 7 in the epidermis of transgenic mice results in development defects in the epidermis and its appendages. J Invest Dermatol 21:2580-90
13. Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, Thome M, Gassler N et al. (2004) BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology 127:1815-20
14. Kruse R, Rutten A, Schweiger N, Jakob E, Mathiak M, Propping P et al. (2003) Frequency of microsatellite instability in unselected sebaceous gland neoplasia and hyperplasia. J Invest Dermatol 120:858-64
15. Li WQ, Kawakami K, Ruszkiewicz A, Bennet G, Moore J, Jacopetta B (2006) BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer 5:2
16. Lipton L, Halford SE, Johnson V, Novelli MR, Jones A, Cummings C et al. (2003) Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63:7595-9
17. Losi L, Luppi G, Benhattar J (2004) Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process. Oncol Rep 12:1221-5
18. E600 - associated senescence-like cell cycle arrest of human naevi. Nature 436:636-7
19. Murphy GF, Elder DE (1991) Non-melanocytic tumors of the skin. In: Rosai J, (ed.). Atlas of tumor pathology, 3rd series. Washington, DC: Armed Forces Institute of Pathology (AFIP), 127-8
20. Naoki K, Chen TH, Richards WG, Sugarbaker DJ, Meyerson M (2002) Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res 62:7001-3
21. Pedroni M, Tamassia MG, Percesepe A, Roncucci L, Benatti P, Lanza G et al. (1999) Microsatellite instability in multiple colorectal tumors. Int J Cancer 81:1-5
22. Pollock MP, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. (2003) High frequency of BRAF mutations in nevi. Nat Genet 33:19-20
23. Ponti G, Ponz de Leon M, Maffei S, Pedroni M, Losi L, Di Gregorio C et al. (2005) Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet 68:1-6
24. Saldanha G, Purnell D, Fletcher A, Potter L, Gillies A, Pringle JH (2004) High BRAF mutation frequency does not characterize all melanocytic tumor types. Int J Cancer 111:705-10
25. Salvatore G, De Falco V, Salerno P, Nappi TC, Pepe S, Troncone G et al. (2006) BRAF is a therapeutic target in aggressive thyroid carcinoma. Clin Cancer Res 12:1623-9
26. Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG et al. (2003) Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362:5-6
27. Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL et al. (2003) Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 63:756-9
28. Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C et al. (2002) Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62:6451-5
29. Zoubolulis CC, Boschnakow A (2001) Chronological ageing and photoageing of the human sebaceous gland. Clin Exp Dermatol 26:600-7